İsrail - İbranice - Ministry of Health

trima israel pharmaceutical products maabarot ltd - levetiracetam - טבליות מצופות פילם - levetiracetam 500 mg - levetiracetam - levetiracetam - - levetrim is indicated as adjunctive therapy in the treatment of partial onset seizures with or without secondary generalisation in adults and children from 4 years of age with epilepsy. - levetrim is indicated as adjunctive therapy in the treatment of myoclonic seizures in adults and adolescents from 12 years of age with juvenile myoclonic epilepsy. - levetrim is indicated as monotherapy in the treatment of partial onset seizures with or without secondary generalization in patient from 16 years of age with newly diagnosed epilepsy. - levetrim is indicated in the treatment of primary gneralized tonic-clonic seizures in adults and adolescents from 12 years of age with idiopathic generalised epilepsy.

İsrail - İbranice - Ministry of Health

trima israel pharmaceutical products maabarot ltd - levetiracetam - טבליות מצופות פילם - levetiracetam 1000 mg - levetiracetam - levetiracetam - - levetrim is indicated as adjunctive therapy in the treatment of partial onset seizures with or without secondary generalisation in adults and children from 4 years of age with epilepsy. - levetrim is indicated as adjunctive therapy in the treatment of myoclonic seizures in adults and adolescents from 12 years of age with juvenile myoclonic epilepsy. - levetrim is indicated as monotherapy in the treatment of partial onset seizures with or without secondary generalization in patient from 16 years of age with newly diagnosed epilepsy. - levetrim is indicated in the treatment of primary gneralized tonic-clonic seizures in adults and adolescents from 12 years of age with idiopathic generalised epilepsy.

İsrail - İbranice - Ministry of Health

trima israel pharmaceutical products maabarot ltd - levetiracetam - תמיסה (פומי) - levetiracetam 100 mg/ml - levetiracetam - levetiracetam - levetrim solution is indicated as:- monotherapy in the treatment of partial onset seizures with or without secondary generalisation in patients from 16 years of age with newly diagnosed epilepsy. - adjunctive therapy:in the treatment of partial onset seizures with or without secondary generalisation in adults and children from 4 years of age with epilepsy.in the treatment of myoclonic seizures in adults and adolescents from 12 years of age with juvenile myoclonic epilepsy. in the treatment of primary generalised tonic-clonic seizures in adults and adolescents from 12 years of age with idiopathic generalised epilepsy

İsrail - İbranice - Ministry of Health

trima israel pharmaceutical products maabarot ltd - solifenacin succinate - טבליה - solifenacin succinate 10 mg - solifenacin

İsrail - İbranice - Ministry of Health

trima israel pharmaceutical products maabarot ltd - solifenacin succinate - טבליה - solifenacin succinate 5 mg - solifenacin

İsrail - İbranice - Ministry of Health

trima israel pharmaceutical products maabarot ltd - dimetindene maleate - ג'ל - dimetindene maleate 0.1 %w/w - dimetindene

İsrail - İbranice - Ministry of Health

fischer pharmaceuticals ltd - benzalkonium chloride - טיפות עיניים - benzalkonium chloride 0.01 % - benzalkonium - benzalkonium - for rinsing and soothing the eyes against irritation due to various causes such as: dust, smoke, plants etc. for first aid use in helping remove a foreign body from the eye.

İsrail - İbranice - Ministry of Health

vitamed pharmaceutical industries ltd - hydroxyethylcellulose - תמיסה לעין - hydroxyethylcellulose 0.4 %w/v - other antiinfectives - to protect the eyes and for lubrication in dry eye conditions, when tear production is inadaquate.

İsrail - İbranice - Ministry of Health

teva pharmaceutical industries ltd, israel - repaglinide - טבליה - repaglinide 0.5 mg - repaglinide - repaglinide - treatment of type ii diabetes.

İsrail - İbranice - Ministry of Health

teva pharmaceutical industries ltd, israel - repaglinide - טבליה - repaglinide 1 mg - repaglinide - repaglinide - treatment of type ii diabetes.